PharmaLectures.com

Courses › Regulatory affairs by region › Middle East and Africa: South Africa SAHPRA and the African Medicines Agency, real and planned

Middle East and Africa: South Africa SAHPRA and the African Medicines Agency, real and planned

Your South African dossiers clear first review and your Africa launch plan holds.

  • 8 audio modulesthree lengths each
  • 1 h 20 min to 6 h 40 minbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • RA, QA, BDwho it is written for

Why this training matters

A dossier in Common Technical Document format fails screening at the South African Health Products Regulatory Authority (SAHPRA), and the launch date slips. Business development cannot say what the African Medicines Agency changes. Months go by.

What changes after this course

Your team files in the layout SAHPRA reviewers expect and plans African launches on routes that exist today, not on rumour. You hold a certificate for each learner and a training record for each person, ready for any audit.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

The Common Technical Document goes to the SAHPRA portal in the layout the screening stage expects, so nobody rewrites it on a Thursday night. Your regulatory affairs team knows what the Medicines and Related Substances Act 101 of 1965 means for classification and labelling before the first draft. Site managers keep the Site Master File ready for a Good Manufacturing Practice inspection.

When SAHPRA asks for your pharmacovigilance system documentation, the file is already current and in one place. Your safety staff know when the MedSafety app is the right tool and when the formal report to SAHPRA is still theirs to file. Local cases and international cases each get the right clock.

Business development stops treating each African country as a separate project. Your leads place the African Medicines Agency's set-up milestones on a calendar, separate what exists from what is only planned, and sequence filings around joint assessments and reliance pathways. The launch plan you take to the board names its assumptions.

Who needs this training

  • Regulatory Affairs Manager

    The portal screens your Common Technical Document and finds it incomplete. After this course, your team builds the file structure reviewers look for, and the dossier reaches review.

  • Quality Assurance Director

    An inspector asks for the Site Master File in the opening hour of a Good Manufacturing Practice inspection. Yours answers the questions before they are asked.

  • Head of Pharmacovigilance

    SAHPRA requests your pharmacovigilance system documentation while an adverse event waits to be reported. You know which route applies, the MedSafety app or the formal report, and which clock is running.

  • Business Development Lead

    The board asks when the product launches across Africa. You answer from the Treaty rollout phases and the reliance routes open today, not from a hopeful guess.

Roles: Business development and export sales, Regulatory affairs, Quality assurance and Qualified Person

Businesses: every kind of pharma company

Countries: India, China, Türkiye, Korea, Japan, Taiwan, Egypt, Gulf and MENA, Brazil and Latin America, Pakistan, Bangladesh and Vietnam, United States, Europe

Selling into: Middle East and Africa

Courses are in English. Other languages on request.

After this course your people can

  1. Structure a Common Technical Document so it passes screening on the SAHPRA submission portal.
  2. Update a Site Master File so it answers the questions a South African Good Manufacturing Practice inspector asks.
  3. Distinguish a MedSafety app report from the formal SAHPRA report a registration holder must file.
  4. Check your pharmacovigilance system documentation against what SAHPRA can request.
  5. Place each African Medicines Agency set-up milestone on your launch calendar and mark what is still planned.
  6. Identify which joint assessment initiatives and reliance pathways apply in your target African markets.
  7. Sequence regional filings around the reliance pathways each target country offers.

What the company gets

  • Your regulatory team clears SAHPRA portal screening without a resubmission loop that moves the launch date.
  • Your manufacturing sites meet a Good Manufacturing Practice inspection with a Site Master File that is current and complete.
  • Your business development team plans African entry on the joint assessment and reliance routes that exist today, and flags the ones still planned.
  • Your pharmacovigilance staff meet SAHPRA reporting deadlines, with a certificate and training record for each learner ready for any auditor.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 8 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing1 h 20 min10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard3 h 20 min25 min a module, for regulatory, quality and business-development staff
Expanded6 h 40 min50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Business development and export salesBriefing1 h 20 min
Regulatory affairsStandard3 h 20 min
Quality assurance and Qualified PersonStandard3 h 20 min

Course outline: 8 modules

8 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Apply the Medicines and Related Substances Act 101 of 1965 under SAHPRA

    • How to read Act 101 of 1965 so your product's classification is settled before the dossier is drafted.
    • What to do when a query lands and nobody knows which SAHPRA contact point owns it.
    • The labelling duties under the Act that your artwork team checks before print, not after.
  2. 2Submit a new drug product application through the SAHPRA portal

    • What to do when SAHPRA screening finds your Common Technical Document incomplete.
    • The file structure reviewers check first, so your dossier is not stopped before anyone reads it.
    • How to give your commercial team a registration timeline that reflects the current review queue.
  3. 3Pass SAHPRA Good Manufacturing Practice site inspections

    • How inspectors use your Site Master File, so you answer their questions before they ask.
    • Why a gap in the Site Master File becomes a non-compliance finding, and how to close it first.
    • The records that show a foreign manufacturing site meets South African requirements.
  4. 4Report adverse reactions to SAHPRA and use the MedSafety app correctly

    • When the MedSafety app fits your duty and when the formal SAHPRA report is still yours to file.
    • What your pharmacovigilance system documentation must show on the day SAHPRA asks for it.
    • How to tell which reporting timelines apply to local cases and which to international ones.
  5. 5Track the African Medicines Agency's set-up milestones on your timeline

    • How the Treaty is meant to coordinate regulators, put in words that work in a board briefing.
    • What is settled about the Agency's set-up, and which signals to watch as it develops.
    • Why national submissions stay in force while the Agency is being set up.
  6. 6Use joint assessments to reach African approvals faster

    • How joint assessments aim to cut the duplicated queries each country sends you.
    • How a reliance pathway lets one authority draw on another trusted authority's assessment.
    • Why clinical trial data requirements still need a country-by-country check under collaborative procedures.
  7. 7Prepare dossiers for SAHPRA data sharing with the African Medicines Agency

    • What the Treaty says about information sharing between regulators, and what it means for your file.
    • The steps to take now so today's dossiers fit tomorrow's joint assessment procedures.
    • Which SAHPRA guideline changes to watch as regional harmonisation work continues.
  8. 8Build a multi-country submission strategy for African markets

    • How to sequence national filings so harmonised guidelines work for you on the later ones.
    • The stakeholders to call early when you plan a multi-country launch in Africa.
    • What a combined SAHPRA and African Medicines Agency roadmap does to your launch dates.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

8 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 1 h 20 min in the briefing length and 6 h 40 min in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for RA, QA, BD. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 72 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team